Development and functional characterization of a murine/human chimeric antibody with specificity for the human interleukin-2 receptor
- 31 July 1993
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 30 (10) , 865-876
- https://doi.org/10.1016/0161-5890(93)90010-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Human IgG subclass pattern of inducing complement‐mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentrationEuropean Journal of Immunology, 1991
- Enhancement of Complement Activation and Cytolysis of Human IgG3 by Deletion of Hinge ExonsScandinavian Journal of Immunology, 1990
- Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal AllograftsNew England Journal of Medicine, 1990
- THE MULTI-SUBUNIT INTERLEUKIN-2 RECEPTORAnnual Review of Biochemistry, 1989
- PROLONGATION OF PRIMATE RENAL ALLOGRAFT SURVIVAL BY ANTI-TAC, AN ANTI-HUMAN IL-2 RECEPTOR MONOCLONAL ANTIBODYTransplantation, 1989
- Reshaping human antibodies for therapyNature, 1988
- Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.The Journal of Experimental Medicine, 1987
- Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice.The Journal of Experimental Medicine, 1985
- The Proteolytic Activation Systems of ComplementAnnual Review of Biochemistry, 1981
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970